SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-015973
Filing Date
2021-11-15
Accepted
2021-11-15 16:08:55
Documents
13
Period of Report
2021-11-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aytu-20211115x8k.htm   iXBRL 8-K 36340
2 EX-99.1 aytu-20211115xex99d1.htm EX-99.1 158541
  Complete submission text file 0001558370-21-015973.txt   330519

Data Files

Seq Description Document Type Size
3 EX-101.SCH aytu-20211115.xsd EX-101.SCH 3033
4 EX-101.LAB aytu-20211115_lab.xml EX-101.LAB 16079
5 EX-101.PRE aytu-20211115_pre.xml EX-101.PRE 10210
6 EXTRACTED XBRL INSTANCE DOCUMENT aytu-20211115x8k_htm.xml XML 4909
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 211410554
SIC: 2834 Pharmaceutical Preparations